The Duopoly of Ten-Valent and 13-Valent Pneumococcal Conjugate Vaccines: Do They Differ?

The Lancet Infectious Diseases - United Kingdom
doi 10.1016/s1473-3099(18)30785-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunogenicity and Reactogenicity of Ten-Valent Versus 13-Valent Pneumococcal Conjugate Vaccines Among Infants in Ho Chi Minh City, Vietnam: A Randomised Controlled Trial

The Lancet Infectious Diseases
Infectious Diseases
2019English

Clinical Efficacy of Pneumococcal Conjugate 13-Valent Vaccine in Young Children

Pediatric pharmacology
2016English

Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in the Czech National Immunization Program

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost-Utility Analysis of 10- And 13-Valent Pneumococcal Conjugate Vaccines: Protection at What Price in the Thai Context?

Vaccine
Molecular MedicinePublic HealthVeterinaryMicrobiology EnvironmentalImmunologyInfectious DiseasesOccupational Health
2013English

Cost-Utility Analysis of 10- And 13-Valent Pneumocococcal Conjugate Vaccines in the Philippines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in an Isolated Pneumococcal Vaccine-Naïve Indigenous Population

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2016English

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy